Merck vs. Ratiopharm, Court of Appeal Helsinki (Helsingin Hovioikeus), 31 December 2010
The Helsinki Court of Appeal found that ratiopharm had infringed Merck’s supplementary protection certificate covering losartan. The Court applied the reversed burden of proof of the Patents Act, which has its basis on Article 34 of the TRIPS Agreement. It further considered that, in the absence of proof to the contrary, the active ingredient losartan…